Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology
Disease Category: Schizophrenia and Schizoaffective Disorders
Trial Information
CAMP Schizophrenia Study
The Schizophrenia Trials Network is currently conducting the
CAMP (Comparison of Antipsychotics for Metabolic Problems) study,
which is aimed at better understanding the risks and benefits
associated with antipsychotic use, especially with regard to the
physical health outcomes of people with psychotic disorders. It is
designed for people with schizophrenia or schizoaffective disorder
who may be considering a medication change because of weight gain,
high cholesterol, or other health problems. All participants will
receive a medication that is FDA-approved for people with
schizophrenia and schizoaffective disorder. The study involves the
atypical antipsychotics Zyprexa, Seroquel, or Risperdal.
To be included in the study, participants
must:
- Have a diagnosis of schizophrenia or schizoaffective disorder,
Be 18-65 years old, and Be stable on Zyprexa, Seroquel, or
Risperdal
- Participants must not be pregnant or breastfeeding.
Barbara Roggero
Psychopharmacology Research Clinic LSUHSC-Shreveport
1501 Kings Highway
Shreveport, LA 71103
Phone: 318-813-2073
Fax: 318-813-2080
EMail: brogge@lsuhsc.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
